Monday June 26th 2017

Posts Tagged ‘Paolo Zamboni’

Controversial treatment creating bitterness in MS Society elections

Controversial treatment creating bitterness in MS Society elections

The Multiple Sclerosis Society’s national board election next week is expected to become a battleground as members rally to shut out supporters of a controversial treatment. An e-mail circulated on Friday urged MS Society supporters to sign up to become members, which [Read More]

Saskatchewan Woman Says MS Operation “Did Wonders”

Saskatchewan Woman Says MS Operation “Did Wonders”

A Rosetown, Sask., woman says she feels “150 per cent better” after receiving a much publicized, but controversial, treatment for her multiple sclerosis. “I’m a different person today than I was four weeks ago,” said Val Hoenecke, a math [Read More]

CCSVI Multiple sclerosis Breakthrough/cure

CCSVI Multiple sclerosis Breakthrough/cure

also Watch this it takes a few seconds to load. www.cbc.ca US scientists are testing a radical new theory that multiple sclerosis (MS) is caused by blockages in the veins that drain the brain. The University of Buffalo team were intrigued by the work of Italian researcher [Read More]

 Page 10 of 10  « First  ... « 6  7  8  9  10 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]